This article was published in Scientific American’s former blog network and reflects the views of the author, not necessarily those of Scientific American As store-based distribution of genetic health ...

Home DNA tests are an accessible way to gain an extensive understanding of your heritage, family history and diaspora. Tests are becoming increasingly affordable and genetic databases are expanding ...

Rose Brystowski, 68, had a choice to make. Others might have found it difficult. She found it easy. Brystowski, of Oak Park, Michigan, wasn't about to let her genetics forfeit her future. Doctors cut ...

With the rise of DNA ancestry tests, it’s easier than ever to learn about your family history and connections. Today, there are many DNA testing services to choose from. They're easy to use. You’ll ...

Best DNA testing kits for uncovering your family history, tried and tested - Use a DNA kit to fill out the branches on your family tree or discover more about your genetic make-up ...

Genetic testing, which has expanded in recent years with advances in technology and the development of consumer products, is on a path to widespread acceptance in the U.S., researchers at UT ...

Americans with European heritage have long been able to pinpoint their ancestry through DNA testing, but it's only in recent years that those with African heritage have been able to trace their ...

On paper, genetic ancestry testing (also known as recreational genetics) sounds like a simple, fun, and exciting process, allowing interested individuals to learn more about their ethnic ancestry and ...

Drugmaker Regeneron Pharmaceuticals is acquiring majority assets of bankrupt genetic testing firm 23andMe Holding for $256 million. The once-sizzling DNA-testing startup filed for bankruptcy in March, ...

New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. As the new year approaches, many of us are setting ...

(Reuters) -Drugmaker Regeneron Pharmaceuticals is acquiring majority assets of bankrupt genetic testing firm 23andMe Holding for $256 million. The once-sizzling DNA-testing startup filed for ...